ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2715

Genetic Variants in TNF, TNFRSF1A, and IL23R Are Associated with Risk of Ankylosing Spondylitis

Jacob Sode1,2,3, Ulla Vogel4, Steffen Bank5, Paal Skytt Andersen6, Merete Lund Hetland7, Henning Locht2, Niels H. H. Heegaard8 and Vibeke Andersen9, 1Department of Autoimmunology and Biomarkers, Statens Serum Institut, Copenhagen, Denmark, 2Department of Rheumatology, Frederiksberg Hospital, Frederiksberg, Denmark, 3Department of Rheumatology, Skåne University Hospital, Lund, Sweden, 4National Research Centre for the Working Environment, Copenhagen, Denmark, 5Institute of Human Genetics, University of Aarhus, Aarhus, Denmark, 6Microbiology & Infection Control, Statens Serum Institut, Copenhagen S, Denmark, 7DANBIO Registry and Departments of Rheumatology, Rigshospitalet (Glostrup and Blegdamsvej), University of Copenhagen, Glostrup, Denmark, 8Department of Autoimmunology & Biomarkers, Statens Serum Institut, Copenhagen, Denmark, 9Odense University Hospital, OPEN (Odense Patient data Explorative Network), Odense, Denmark

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Ankylosing spondylitis (AS), disease susceptibility and rheumatoid arthritis (RA), IL-23

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Spondylarthropathies Psoriatic Arthritis – Pathogenesis, Etiology - Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: The objective of this study was to evaluate single nucleotide polymorphisms (SNPs) involved in TNFα signaling, NF-κB activation, interferon-γ signaling, or pattern recognition receptor signaling pathways (TLRs and inflammasome) and their association with ankylosing spondylitis (AS) and rheumatoid arthritis (RA) susceptibility. The genotyped SNPs have known functional effects or previously reported associations with chronic autoimmune disease.

Methods: In a cross-sectional study, we genotyped 53 SNPs in 709 AS patients and 58 SNPs in 538 RA patients from Denmark. Prospectively collected clinical data were obtained from the DANBIO registry. Genotype distributions among cases were compared with 796 population-based controls. Odds ratios for minor allele carriers among cases adjusted for gender and age were calculated assuming additive genetic effects. Correction for multiple testing was performed using false discovery rate (FDR), and associations with FDR q-values <0.1 were considered significant.

Results: We find a decreased risk of AS in minor allele carriers of two SNPs in TNF (rs1800629: odds ratio(OR)=0.59, 95% confidence interval(CI): 0.47-0.74, p=3*10-6, q=1*10-4; rs361525: OR=0.48, CI: 0.31-0.75, p=0.001, q=0.02), and of IL23R rs11209026 (OR= 0.60, CI: 0.43-0.85, p=0.004, q=0.05). Carriers of the minor allele of TNFRSF1A rs4149570 (OR=1.32, CI: 1.14-1.54, p= 3*10-04, q=0.007) had increased risk of AS. Among RA patients, no statistically significant associations were observed. However, a previously reported RA risk allele in PTPN22(rs2476601) showed a similar trend in this cohort (OR=1.39, CI: 1.06-1.82, p=0.016, q=0.3).

Conclusion: In a Danish population, this study confirms a previously reported locus in the interleukin-23 receptor (rs11209026) as less common in AS patients, and identifies genetic variation in TNFα (rs1800629, rs361525) and TNF receptor-1 (rs4149570) as putative loci associated with AS. Among RA patients, no SNPs reached significant association but the previously reported risk allele PTPN22 rs2476601 showed a borderline association with disease susceptibility.


Disclosure: J. Sode, None; U. Vogel, None; S. Bank, None; P. S. Andersen, None; M. Lund Hetland, AbbVie, BMS, MSD, Roche, Pfizer, UCB, Crescendo, 2; H. Locht, None; N. H. H. Heegaard, None; V. Andersen, None.

To cite this abstract in AMA style:

Sode J, Vogel U, Bank S, Andersen PS, Lund Hetland M, Locht H, Heegaard NHH, Andersen V. Genetic Variants in TNF, TNFRSF1A, and IL23R Are Associated with Risk of Ankylosing Spondylitis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/genetic-variants-in-tnf-tnfrsf1a-and-il23r-are-associated-with-risk-of-ankylosing-spondylitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/genetic-variants-in-tnf-tnfrsf1a-and-il23r-are-associated-with-risk-of-ankylosing-spondylitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology